Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russ B Altman

Showing results (131-140 of 420) with videos related to

Pageof 42
Sort By:
Journal of Medical Internet Research|March 25, 2015
Ranking adverse drug reactions with crowdsourcingAssaf Gottlieb, Robert Hoehndorf, Michel Dumontier, et al.
Pharmacogenetics and Genomics|November 10, 2009
PharmGKB summary: very important pharmacogene information for angiotensin-converting enzymeCaroline F Thorn, Teri E Klein, Russ B Altman
Journal of the American Medical Informatics Association : JAMIA|July 24, 2013
Response to 'Use of an algorithm for identifying hidden drug-drug interactions in adverse event reports' by Gooden et alNicholas P Tatonetti, Joshua C Denny, Russ B Altman
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|January 31, 2008
Combining molecular dynamics and machine learning to improve protein function recognitionDariya S Glazer, Randall J Radmer, Russ B Altman
Journal of the American Medical Informatics Association : JAMIA|June 17, 2011
A novel signal detection algorithm for identifying hidden drug-drug interactions in adverse event reportsNicholas P Tatonetti, Guy Haskin Fernald, Russ B Altman
Methods in Molecular Biology (Clifton, N.J.)|August 16, 2005
PharmGKB: the pharmacogenetics and pharmacogenomics knowledge baseCaroline F Thorn, Teri E Klein, Russ B Altman
Human Mutation|March 12, 2008
PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogeneticsRyan P Owen, Russ B Altman, Teri E Klein
Plos Computational Biology|April 11, 2022
Construction of disease-specific cytokine profiles by associating disease genes with immune responsesTianyun Liu, Shiyin Wang, Michael Wornow, et al.
Human Mutation|February 11, 2011
Databases in the area of pharmacogeneticsSarah C Sim, Russ B Altman, Magnus Ingelman-Sundberg
MLO: Medical Laboratory Observer|April 14, 2006
Pharmacogenomics: The relevance of emerging genotyping technologiesTina Hernandez-Boussard, Teri E Klein, Russ B Altman
Pageof 42

Showing results (131-140 of 420) with videos related to

Sort By:
Pageof 42
Journal of Medical Internet Research|March 25, 2015
Ranking adverse drug reactions with crowdsourcingAssaf Gottlieb, Robert Hoehndorf, Michel Dumontier, et al.
Pharmacogenetics and Genomics|November 10, 2009
PharmGKB summary: very important pharmacogene information for angiotensin-converting enzymeCaroline F Thorn, Teri E Klein, Russ B Altman
Journal of the American Medical Informatics Association : JAMIA|July 24, 2013
Response to 'Use of an algorithm for identifying hidden drug-drug interactions in adverse event reports' by Gooden et alNicholas P Tatonetti, Joshua C Denny, Russ B Altman
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|January 31, 2008
Combining molecular dynamics and machine learning to improve protein function recognitionDariya S Glazer, Randall J Radmer, Russ B Altman
Journal of the American Medical Informatics Association : JAMIA|June 17, 2011
A novel signal detection algorithm for identifying hidden drug-drug interactions in adverse event reportsNicholas P Tatonetti, Guy Haskin Fernald, Russ B Altman
Methods in Molecular Biology (Clifton, N.J.)|August 16, 2005
PharmGKB: the pharmacogenetics and pharmacogenomics knowledge baseCaroline F Thorn, Teri E Klein, Russ B Altman
Human Mutation|March 12, 2008
PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogeneticsRyan P Owen, Russ B Altman, Teri E Klein
Plos Computational Biology|April 11, 2022
Construction of disease-specific cytokine profiles by associating disease genes with immune responsesTianyun Liu, Shiyin Wang, Michael Wornow, et al.
Human Mutation|February 11, 2011
Databases in the area of pharmacogeneticsSarah C Sim, Russ B Altman, Magnus Ingelman-Sundberg
MLO: Medical Laboratory Observer|April 14, 2006
Pharmacogenomics: The relevance of emerging genotyping technologiesTina Hernandez-Boussard, Teri E Klein, Russ B Altman
Pageof 42